Market Cap 1.24B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 8,511,801
Avg Vol 5,672,108
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 37%
Beta 1.02
Analysts Strong Sell
Price Target $10.14

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
Amires
Amires May. 21 at 4:06 AM
$ABCL smart money buying at bargain with such high volumes lately... Look at recent Baker bros filing.... They must know something and like to be adding at these levels knowing that once this baby takes off, it is too late to add... Shorts, please defend your list position more... Feed the fire as much as possible ... Longs buckle up, fly time is closeeeee......
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 20 at 11:11 PM
$ABCL If the rumors are true hold on to your seats the next few days will be very exciting 😉👀😊
1 · Reply
whereishbc
whereishbc May. 20 at 11:04 PM
$ABCL do they take it back to $4.10 tomorrow? Could see it. Bio was on fire today. But a great buy if so.
1 · Reply
Art_BunyaaHa
Art_BunyaaHa May. 20 at 8:41 PM
$ABCL looking squeezy #nvda
0 · Reply
Plutten1973
Plutten1973 May. 20 at 6:52 PM
$ABCL interesting!
2 · Reply
Plan2TradeTrade2Plan
Plan2TradeTrade2Plan May. 20 at 5:54 PM
0 · Reply
Odoji
Odoji May. 20 at 4:56 PM
$ABCL 💉
0 · Reply
ispy
ispy May. 20 at 4:20 PM
$ABCL be kind of cool if this triggers a stop trade today spike away
0 · Reply
tradersunion353
tradersunion353 May. 20 at 4:18 PM
$ABCL overhyped junkie must he trading at 6 to 7 dollars after phase 1 data but dropped to 3.90s lets see if this scam gonna hold on to the little bump
1 · Reply
ispy
ispy May. 20 at 4:07 PM
$ABCL i wouldn't be surprised of an all stock purchase offering from a large player at this point.
4 · Reply
Latest News on ABCL
AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 8 days ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Q1 Earnings Call Highlights

May 11, 2026, 7:08 PM EDT - 9 days ago

AbCellera Biologics Q1 Earnings Call Highlights


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 9 days ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 9 days ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 9 days ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 9 days ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 15 days ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 21 days ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 21 days ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 5 weeks ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 3 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 3 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 3 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 4 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 6 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 6 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 6 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 6 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera appoints Sarah Noonberg as Chief Medical Officer

2025-09-10T13:20:54.000Z - 9 months ago

AbCellera appoints Sarah Noonberg as Chief Medical Officer

MGX


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 9 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera doses first participants in Phase 1 trial of ABCL575

2025-08-27T13:20:26.000Z - 9 months ago

AbCellera doses first participants in Phase 1 trial of ABCL575


AbCellera price target raised to $7 from $5 at BMO Capital

2025-08-08T13:26:29.000Z - 10 months ago

AbCellera price target raised to $7 from $5 at BMO Capital


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 10 months ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera assumed with an Outperform at Leerink

2025-07-07T10:40:33.000Z - 11 months ago

AbCellera assumed with an Outperform at Leerink


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


Amires
Amires May. 21 at 4:06 AM
$ABCL smart money buying at bargain with such high volumes lately... Look at recent Baker bros filing.... They must know something and like to be adding at these levels knowing that once this baby takes off, it is too late to add... Shorts, please defend your list position more... Feed the fire as much as possible ... Longs buckle up, fly time is closeeeee......
0 · Reply
Stocktradesmoon
Stocktradesmoon May. 20 at 11:11 PM
$ABCL If the rumors are true hold on to your seats the next few days will be very exciting 😉👀😊
1 · Reply
whereishbc
whereishbc May. 20 at 11:04 PM
$ABCL do they take it back to $4.10 tomorrow? Could see it. Bio was on fire today. But a great buy if so.
1 · Reply
Art_BunyaaHa
Art_BunyaaHa May. 20 at 8:41 PM
$ABCL looking squeezy #nvda
0 · Reply
Plutten1973
Plutten1973 May. 20 at 6:52 PM
$ABCL interesting!
2 · Reply
Plan2TradeTrade2Plan
Plan2TradeTrade2Plan May. 20 at 5:54 PM
0 · Reply
Odoji
Odoji May. 20 at 4:56 PM
$ABCL 💉
0 · Reply
ispy
ispy May. 20 at 4:20 PM
$ABCL be kind of cool if this triggers a stop trade today spike away
0 · Reply
tradersunion353
tradersunion353 May. 20 at 4:18 PM
$ABCL overhyped junkie must he trading at 6 to 7 dollars after phase 1 data but dropped to 3.90s lets see if this scam gonna hold on to the little bump
1 · Reply
ispy
ispy May. 20 at 4:07 PM
$ABCL i wouldn't be surprised of an all stock purchase offering from a large player at this point.
4 · Reply
8008track
8008track May. 20 at 3:30 PM
$ABCL I don’t have a crystal ball so I may be totally wrong but some people may be playing with fire. If this starts to truly take off, then you will be left behind. Generational company potential. These opportunities don’t come along everyday at this price. This may drop but then again it may go to the moon.
1 · Reply
DeMampCamp
DeMampCamp May. 20 at 3:04 PM
0 · Reply
Amires
Amires May. 20 at 3:03 PM
$ABCL The massive volume over the last few weeks isn’t retail—it’s smart institutional money quietly accumulating. 🐋💼 Shorts are playing an incredibly high-risk game trying to suppress this, but they are just getting filled until the squeeze inevitably comes. 🚀🔥 Institutions are the smart money here. They know exactly what is coming long-term and have the patience to wait it out. Easy game for them while the bears take on massive risk. Hold and let the smart money win the war. 🧬💰 #biotech #shortsqueeze #accumulation
2 · Reply
TradeWinner
TradeWinner May. 20 at 2:49 PM
$ABCL ho hum. Hold your shares. Going higher IMHO.
0 · Reply
MorganHoratio
MorganHoratio May. 20 at 2:38 PM
Do you think this investment portfolio is suitable for young people under the age of 30?(PART2) $AIRJ: 3.07% $ABCL: 1.93% $RDW: 1.91% $OSCR: 1.84% $NOW: 1.74% Under 30 is the time for risks, but this looks less like a personal portfolio and more like a micro-VC fund! The biggest trait here is extreme diversification. The top holding $AIRJ is only around 3%, surrounded by high-beta dark horses like $ABCL (biotech), $RDW (space infra), and the surging AI-health play $OSCR. Only 1.7% is anchored in a tech giant like $NOW. This "spray and pray" strategy caps your downside but dilutes explosive gains. For young investors with limited capital, is it better to diversify like this, or concentrate fire on high-conviction mega-caps? Drop your thesis below! Let's discuss! 👇
0 · Reply
tkstockpicker
tkstockpicker May. 20 at 2:34 PM
$ABCL Sold this lot and banked AGAIN
0 · Reply
ispy
ispy May. 20 at 2:31 PM
$ABCL moving on Volume kids... wassup?
0 · Reply
bonecrack_benny
bonecrack_benny May. 20 at 2:26 PM
$ABCL Marry me, Carl.
0 · Reply
whereishbc
whereishbc May. 20 at 2:17 PM
$ABCL good job
0 · Reply
Stockingtrade
Stockingtrade May. 20 at 1:41 PM
$ABCL lending rate in the last 2 weeks has more than tripled, now 5.46. Getting expensive to borrow for shorts!
2 · Reply
Ckkung71
Ckkung71 May. 20 at 1:22 PM
$ABCL Robot trading
0 · Reply
tradersunion353
tradersunion353 May. 20 at 12:55 PM
$ABCL finally market is realizing this is overhyped junk management backed by few x accounts were pumping this scam yet they are not able to move a dime
1 · Reply